Stanford Bioengineers Develop Reverse Translation Technique to Sequence Rare Proteins Using Low Cost DNA Platforms

New Stanford research converts proteins to DNA for rapid sequencing, offering 1,000x more sensitivity than mass spectrometry for single cell analysis.

By: AXL Media

Published: Mar 18, 2026, 8:17 AM EDT

Source: Information for this report was sourced from Stanford University

Converting Biological Machinery Into Digital Code

Stanford University bioengineers have successfully bridged the technological gap between genomic sequencing and protein analysis by developing a method to run the natural process of protein synthesis in reverse. While DNA acts as a blueprint, proteins are the actual machinery that executes cellular functions, yet they have remained notoriously difficult to map due to their complex 20 amino acid structure. By converting these amino acid sequences back into DNA strands, researchers can now utilize the massive, cost effective infrastructure built for DNA sequencing over the last two decades to read the functional workhorses of the cell.

The Complexity Barrier of Amino Acid Identification

The fundamental challenge in proteomics has always been the sheer scale and variety of the molecules involved compared to the relatively simple four base architecture of DNA. Amino acids are significantly smaller than nucleic acids and exist in twenty distinct variations, making them difficult for standard laboratory hardware to distinguish reliably. Senior author H. Tom Soh noted that while DNA technology has advanced at a blistering pace, protein sequencing has lagged behind, often requiring massive samples to yield even modest data. This new approach seeks to standardize protein reading by leveraging the chemical precision of DNA barcoding to label and identify each link in a peptide chain.

Surpassing the Limits of Mass Spectrometry

Current industry standards, primarily mass spectrometry, often suffer from low efficiency, typically capturing only a tiny fraction of the molecules present in a given sample. According to research engineer Liwei Zheng, the new Stanford method can potentially visualize 1,000 times more molecules from the same sample than existing techniques. This leap in sensitivity is critical for identifying rare proteins that may be the primary drivers of disease but are usually lost in the "noise" of bulk cellular analysis. By achieving single molecule resolution, scientists can now observe the minute differences that cause seemingly identical cells to react differently to the same stimulus.